Celltrion Healthcare Co., Ltd.
http://www.celltrionhealthcare.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Celltrion Healthcare Co., Ltd.
Celltrion Juggles Biosimilar Market Share As It Shifts To Direct Marketing
Celltrion Healthcare was ultimately able to increase its revenue by 16.7%, with stronger growth expected in H2.
AstraZeneca’s Evusheld Wins EU Marketing Nod For Preventing COVID-19
The European Commission is expected to make a “rapid decision” on the European Medicines Agency’s recommendation today that Evusheld should be approved.
Celltrion Celebrates Brazilian Tender Win For Infliximab
Celltrion’s Remsima infliximab biosimilar has won a Brazilian federal tender as well as several individual state bids, following earlier awards for the Korean firm’s Truxima (rituximab) and Herzuma (trastuzumab) biosimilars.
Seventeen And Counting – Bumper Crop Of New EU Filings
Orphan drugs and COVID-19 products are among the latest filings under review by the European Medicines Agency for potential pan-EU approval.